Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03958045
Title Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aman Chauhan
Indications

lung small cell carcinoma

Therapies

Nivolumab + Rucaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.